Inventor · disambiguated record
Lars Østergaard Pedersen
Also filed as: PEDERSEN LARS OSTERGAARD · Pedersen Lars Østergaard
10 granted patents·2 pending applications·64 citations·filing 2003–2021
89Inventor score
Files withH LUNDBECK AS11
Top patents by PatentIndex Score
12 records- 0195US11111290B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Sep 7, 2021·6 cites·9 claims
- 0295US10196439B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2016·Granted Feb 5, 2019·23 cites·20 claims
- 0394US10934348B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Mar 2, 2021·6 cites·11 claims
- 0492US10647762B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted May 12, 2020·5 cites·3 claims
- 0590US10995137B2Antibodies specific for hyperphosphorlated tau for the treatment of ocular diseasesH LUNDBECK AS·Filed 2018·Granted May 4, 2021·7 cites·13 claims
- 0689US10562962B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2018·Granted Feb 18, 2020·6 cites·11 claims
- 0789US10487142B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Nov 26, 2019·5 cites·3 claims
- 0888US10472415B2Antibodies specific for hyperphosphorylated tau and methods of useH LUNDBECK AS·Filed 2017·Granted Nov 12, 2019·5 cites·3 claims
- 0987US11739140B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2021·Granted Aug 29, 2023·1 cites·12 claims
- 1078US12129289B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2021·Granted Oct 29, 2024·0 cites·15 claims
- 1151US2019275125A1Abeta variants, assay, method and treatment of alzheimer's diseaseH LUNDBECK AS·Filed 2019·Application pending·0 cites
- 1241US2004122216A1Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organsFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →